Evidence map›Paper›PMID 40401924›Full record

ReviewJournal of bacteriology2025

From lab reagent to metabolite: the riboswitch ligand guanidine as a relevant compound in bacterial physiology.

Payton Bowman, Hubert Salvail

Abstract readReview
In one paragraph

Review in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Payton BowmanDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida, USA.
Hubert SalvailDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida, USA.ORCID 0000-0001-9107-8660

Funding

College of Medicine, University of Central Florida
6 · The paper itself

Abstract

Efforts of the last 20 years in validating novel riboswitches led to the identification of numerous new motifs recognizing compounds with well-established biological functions. However, the recent characterization of widespread classes of riboswitches binding the nitrogen-rich compound guanidine raised questions regarding its physiological significance that has so far remained elusive. Recent findings established that certain bacterial species assimilate guanidine as a nitrogen source via guanidine-specific enzymes and transporters and that complete ammonium oxidizers can use it as a sole source of energy, reductant, and nitrogen. The frequent association of guanidine riboswitches with genes encoding guanidine efflux transporters also hints that bacteria may experience the burden of guanidine as a stressor during their lifestyle. A major gap in understanding the biology of guanidine resides in its natural source. While metabolic pathways responsible for guanidine synthesis were defined in plants, only a few guanidine-producing enzymes have been identified in bacteria, despite indications that the model organism

Indexed as

BacteriaBacterial Physiological PhenomenaGuanidineRiboswitchGene Expression Regulation, BacterialLigandsGuanidineLigandsRiboswitchefflux pumpguanidineguanidiniumnitrogen metabolismriboswitchstress response

Identifiers

PMID40401924
PMCPMC12186494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.